German Medtech Protembis Gets €20 Million EIB Backing for Technology to Protect Brain During Heart Treatment
EIB offers Protembis venture debt for next-generation technology to reduce risk of brain injury in patients undergoing catheter-based heart treatment Financing is to complete clinical trials and support marketing of “ProtEmbo” cerebral embolic protection system Funding will accelerate research, development... Read More →
CMS Establishes National Payment for AI Breakthrough in Prostate Cancer Diagnosis, Unfold AI
CULVER CITY, Calif., July 25, 2024 /PRNewswire/ — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, today announces the Centers for Medicare & Medicaid Services (CMS) has assigned a national payment rate for the... Read More →
Edwards Lifesciences to spend $1.2B on two more M&A deals
Edwards Lifesciences is continuing its M&A run with two more major deals. The cardiac device company announced yesterday evening that it will spend $1.2 billion to acquire two companies: JenaValve Technology and Endotronix. The news came at the same time... Read More →
Sutter Health to deploy Flosonics Medical’s Doppler ultrasound device
The FloPatch hands-free device can measure blood flow and heart function in relation to IV fluid volume. US-based integrated healthcare system Sutter Health is set to implement Flosonics Medical’s wireless, wearable Doppler ultrasound device, FloPatch, to enhance the safety of... Read More →
eCential Robotics Receives FDA 510(k) Clearance for Spine Navigation and Robotic-Assistance Device
GIÈRES (GRENOBLE), France and NASHVILLE, Tenn., July 22, 2024 /PRNewswire/ — eCential Robotics is proud to announce that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an innovative Spine Navigation and Robotic-Assistance Device. This... Read More →
X-ZELL outperforms traditional immunostaining in German landmark study
“It’s the first time in decades a new technology has come along that could genuinely change how we diagnose cancers from minimally invasive samples.”— PD Dr Achim Battmann LEIPZIG, GERMANY, July 17, 2024 / EINPresswire.com / — New research from... Read More →
Ryght Joins Prestigious CancerX Program to Accelerate Innovation in Cancer Research
LAGUNA BEACH, Calif., July 17, 2024 /PRNewswire/ — Ryght, a leading enterprise generative AI (GenAI) technology company dedicated to improving clinical research, proudly announces its new partnership with CancerX, a public-private partnership aimed at boosting innovation in the fight against... Read More →
Nurami Medical Awarded a €2.5 Million EIC Grant to Accelerate Soft Tissue Repair
HAIFA, Israel, July 16, 2024 /PRNewswire/ — Nurami Medical, a pioneering developer of soft tissue repair solutions, announced today that it has been awarded blended financing which includes a €2.5 million grant and additional equity investment from the European Innovation... Read More →
Vectorious Medical Technologies Announces First U.S. Patient Implanted with the V-LAP Left Atrial Pressure Sensor
TEL AVIV, Israel, July 16, 2024 /PRNewswire/ — A patient in Cincinnati has become the first in the United States to receive an innovative system that enables remote monitoring of his heart and congestion status, as well as self-adjustment of... Read More →
Innoblative Announces Successful First-in-Human Use of its Novel Electrosurgical Device for Breast Cancer Treatment
The company’s SIRA® RFA Electrosurgical Device designed specifically for patients undergoing breast-conserving surgery (BCS) Breast cancer is the second most common cancer worldwide with over 2.3M new cases each year CHICAGO, July 16, 2024 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative),... Read More →